OPTN - OptiNose Inc Net earnings per share (EPS TTM)
OptiNose, Inc. (OPTN) is expanding its reach among sinusitis patients through effective drug delivery. High development costs for sprayers and patent protection create a significant barrier to entry for competitors. The growth in XHANCE prescriptions is bringing the company closer to profitability. The rolling earnings per share trend demonstrates the dynamics of this process, and the value of -3.00 reflects the metric's balance.
Analytical breakdowns and data insights for company OptiNose Inc (OPTN)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
- net income and valuation multiples indicators:
OPTN - Company Profit|Expected Profit OptiNose, Inc.|OPTN - Market Cap to Earnings|Future Price to Earnings OptiNose|OPTN - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple OptiNose, Inc.|OPTN - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months OptiNose|OPTN - Earnings per share for the trailing year|Quarterly EPS earnings growth optinose.com|OPTN - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year OptiNose, Inc.
- revenue and sales proceeds data:
Summary company analysis:OptiNose, Inc. - OPTN
OptiNose, Inc. (OPTN) is expanding the distribution of its nasal spray through strategic partnerships with retail chains. This indicator reflects the net profit per common share over the last twelve months. A positive trend indicates the efficiency of the operating model and an increase in the real value of capital. It is critical for investors to compare current values with the historical average to assess business sustainability. The price action of net profit per share allows for the timely identification of an overbought asset.
Who OptiNose, Inc. competes with
HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia LQDA|Galapagos N.V. (GLPG) - Net earnings per one share for the last twelve months|ANIP - Earnings per share for the last twelve months|Earnings per one share for the last 12 months MNKD|AMPH (Amphastar Pharmaceuticals) - Net earnings per share for the last 12 months|PCRX: Earnings per share for the last four quarters|SPRY (ARS Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Theravance Biopharma Inc (TBPH) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Aquestive Pharma (AQST)|scpharmaceuticals.com - Earnings per share for the last 12 months|Earnings per share for the last twelve months Tectonic Therapeutic TECX|tonixpharma.com (TNXP) - Net earnings per one share for the last twelve months|SXTC - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Eupraxia Pharmaceuticals EPRX|BHST: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Invizyne (EXOZ)|Net earnings per share for the last 12 months ORMP|ENTX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) HYFT|Net earnings per share for the last four quarters ABVC BioPharma Inc.|Earnings per share for the last twelve months Cumberland Pharma CPIX|QNTM: Earnings per share for the last 12 months|FibroGen, Inc. - Net earnings per share (EPS TTM)|telomirpharma.com (TELO) - Net earnings per share for the last 12 months|RANI (ranitherapeutics.com) - Net earnings per share for the last 12 months|SNYR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Rallybio Corp|Net earnings per one share for the last twelve months Lexaria LEXX|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|PTHL: Earnings per one share for the last 12 months|Aptorum Group - Net earnings per share for the last 12 months|Earnings per share for the last four quarters LYRA (Lyra Therapeutics Inc.)|IBO - Earnings per share for the last twelve months|TNFA (TNF Pharmaceuticals) - Earnings per share for the last 12 months|cbdmd.com (YCBD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PRFX (painreform.com)|CYTO (Altamira Therapeutics Ltd) - Net earnings per share (EPS TTM)|LIPO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|Net earnings per share (EPS TTM) Procaps Group Corp (PROC)|Earnings per share for the last twelve months Petros Pharmaceuticals PTPI|Earnings per share for the trailing year QLI|SLRN - Earnings per share for the last twelve months|TFF Pharmaceuticals Inc. (TFFP) - Net earnings per share for the last 12 months
